MSN 621 Final Exam Questions With
Complete Solutions
Course
MSN 621
Question 1: Cardiac Output and Afterload
Q: A patient with chronic hypertension develops left ventricular hypertrophy. What is the
pathophysiologic mechanism behind this change?
A: Chronic hypertension increases afterload, forcing the left ventricle to work harder to eject
blood. This sustained pressure leads to concentric hypertrophy, a compensatory thickening of
the ventricular wall to maintain cardiac output. Over time, this can decrease compliance and lead
to diastolic heart failure.
Question 2: Renin-Angiotensin-Aldosterone System (RAAS)
Q: Explain how the activation of the RAAS contributes to the pathophysiology of heart failure.
A: In heart failure, decreased perfusion to the kidneys triggers renin release, activating RAAS.
This leads to angiotensin II–mediated vasoconstriction and aldosterone-induced sodium and
water retention, both of which increase preload and afterload, worsening volume overload
and contributing to ventricular remodeling and progression of heart failure.
Question 3: COPD Pathophysiology
Q: What are the key differences in pathophysiology between chronic bronchitis and emphysema
in COPD?
A:
Chronic bronchitis: Inflammation and mucus gland hyperplasia cause airway
obstruction due to excessive mucus, leading to productive cough and hypoxemia.
Emphysema: Destruction of alveolar walls causes loss of elastic recoil and air
trapping, resulting in hyperinflation, dyspnea, and reduced surface area for gas
exchange.
Question 4: Type 2 Diabetes Mellitus
Q: Describe the pathophysiological basis for hyperglycemia in Type 2 Diabetes Mellitus.
,A: T2DM is characterized by insulin resistance in peripheral tissues and relative insulin
deficiency due to beta-cell dysfunction. The liver increases gluconeogenesis, and glucose uptake
in muscle and fat is impaired, resulting in chronic hyperglycemia and associated metabolic
complications.
Question 5: Acute Kidney Injury (AKI)
Q: A patient develops AKI following sepsis. Which type of AKI is most likely, and what is its
pathophysiology?
A: Intrinsic AKI, particularly acute tubular necrosis (ATN), is common in sepsis due to
ischemia and inflammation damaging the renal tubules. This impairs filtration and reabsorption,
causing azotemia, oliguria, and electrolyte imbalances.
Question 6: Asthma Exacerbation
Q: What are the key pathophysiological features during an asthma attack?
A: An asthma exacerbation involves:
Bronchial smooth muscle constriction (bronchospasm)
Airway inflammation
Increased mucus production
These cause airway narrowing, increased airway resistance, wheezing, and dyspnea.
Question 7: Iron Deficiency Anemia
Q: A patient presents with fatigue and pallor. Labs show microcytic, hypochromic anemia. What
is the underlying pathophysiology?
A: Iron deficiency impairs hemoglobin synthesis, leading to the production of smaller
(microcytic), pale (hypochromic) red blood cells. This reduces oxygen-carrying capacity,
causing tissue hypoxia, which manifests as fatigue, pallor, and tachycardia.
Question 8: Stroke (Ischemic)
Q: What is the pathophysiologic mechanism of ischemic stroke?
,A: Ischemic stroke occurs due to arterial occlusion (commonly from a thrombus or embolus),
leading to reduced cerebral blood flow. This causes neuronal ischemia, ATP depletion,
cytotoxic edema, and cell death in affected brain regions if not reversed quickly.
Question 9: Systemic Lupus Erythematosus (SLE)
Q: How does autoimmunity contribute to the multi-system effects of SLE?
A: In SLE, autoantibodies (e.g., ANA, anti-dsDNA) form immune complexes that deposit in
tissues like skin, kidneys, and joints. These complexes trigger complement activation, leading
to inflammation, vasculitis, and tissue damage, resulting in the multisystemic symptoms.
Question 10: Alzheimer’s Disease
Q: Describe the pathophysiological changes in the brain associated with Alzheimer’s disease.
A: Alzheimer’s involves:
Amyloid-beta plaque accumulation outside neurons
Neurofibrillary tangles (tau protein) inside neurons
These changes cause neuronal death, synaptic loss, and cortical atrophy, leading to
progressive memory loss, cognitive decline, and functional impairment.
Question 11: Sepsis and Septic Shock
Q: Describe the pathophysiology of septic shock.
A: Septic shock arises from an overwhelming infection that triggers a systemic inflammatory
response. Cytokine release leads to widespread vasodilation, increased capillary
permeability, and decreased systemic vascular resistance. This causes hypotension, tissue
hypoperfusion, and ultimately multiple organ dysfunction syndrome (MODS) if untreated.
Question 12: Hepatic Encephalopathy
Q: What causes hepatic encephalopathy in liver failure?
A: The failing liver cannot detoxify ammonia, a byproduct of protein metabolism. Ammonia
crosses the blood-brain barrier and alters neurotransmission, leading to cerebral edema, altered
mental status, asterixis, and potentially coma.
Question 13: Graves' Disease
, Q: What is the pathophysiology behind Graves' disease?
A: Graves' is an autoimmune hyperthyroidism. TSI antibodies (thyroid-stimulating
immunoglobulins) mimic TSH, stimulating the thyroid to overproduce T3 and T4. This leads to
increased metabolism, goiter, and symptoms like tachycardia, weight loss, and
exophthalmos.
Question 14: Multiple Sclerosis (MS)
Q: What is the pathophysiology of multiple sclerosis?
A: MS is an autoimmune disease where T cells attack myelin in the central nervous system,
causing demyelination, inflammation, and axonal damage. This disrupts nerve signal
conduction, resulting in motor, sensory, and cognitive impairments.
Question 15: Diabetic Ketoacidosis (DKA)
Q: Explain the key pathophysiological events in DKA.
A: In type 1 diabetes, lack of insulin prevents glucose uptake, leading to lipolysis and ketone
production for energy. Accumulation of ketones causes metabolic acidosis, dehydration,
electrolyte imbalances, and Kussmaul respirations.
Question 16: Chronic Kidney Disease (CKD)
Q: What are the systemic consequences of CKD?
A: CKD leads to:
Uremia (toxin buildup)
Anemia (↓ erythropoietin)
Hypertension (RAAS activation)
Osteodystrophy (↓ vitamin D activation and ↑ phosphate)
Metabolic acidosis
This contributes to multisystem dysfunction.
Question 17: Peptic Ulcer Disease
Q: How does H. pylori infection contribute to peptic ulcer formation?
Complete Solutions
Course
MSN 621
Question 1: Cardiac Output and Afterload
Q: A patient with chronic hypertension develops left ventricular hypertrophy. What is the
pathophysiologic mechanism behind this change?
A: Chronic hypertension increases afterload, forcing the left ventricle to work harder to eject
blood. This sustained pressure leads to concentric hypertrophy, a compensatory thickening of
the ventricular wall to maintain cardiac output. Over time, this can decrease compliance and lead
to diastolic heart failure.
Question 2: Renin-Angiotensin-Aldosterone System (RAAS)
Q: Explain how the activation of the RAAS contributes to the pathophysiology of heart failure.
A: In heart failure, decreased perfusion to the kidneys triggers renin release, activating RAAS.
This leads to angiotensin II–mediated vasoconstriction and aldosterone-induced sodium and
water retention, both of which increase preload and afterload, worsening volume overload
and contributing to ventricular remodeling and progression of heart failure.
Question 3: COPD Pathophysiology
Q: What are the key differences in pathophysiology between chronic bronchitis and emphysema
in COPD?
A:
Chronic bronchitis: Inflammation and mucus gland hyperplasia cause airway
obstruction due to excessive mucus, leading to productive cough and hypoxemia.
Emphysema: Destruction of alveolar walls causes loss of elastic recoil and air
trapping, resulting in hyperinflation, dyspnea, and reduced surface area for gas
exchange.
Question 4: Type 2 Diabetes Mellitus
Q: Describe the pathophysiological basis for hyperglycemia in Type 2 Diabetes Mellitus.
,A: T2DM is characterized by insulin resistance in peripheral tissues and relative insulin
deficiency due to beta-cell dysfunction. The liver increases gluconeogenesis, and glucose uptake
in muscle and fat is impaired, resulting in chronic hyperglycemia and associated metabolic
complications.
Question 5: Acute Kidney Injury (AKI)
Q: A patient develops AKI following sepsis. Which type of AKI is most likely, and what is its
pathophysiology?
A: Intrinsic AKI, particularly acute tubular necrosis (ATN), is common in sepsis due to
ischemia and inflammation damaging the renal tubules. This impairs filtration and reabsorption,
causing azotemia, oliguria, and electrolyte imbalances.
Question 6: Asthma Exacerbation
Q: What are the key pathophysiological features during an asthma attack?
A: An asthma exacerbation involves:
Bronchial smooth muscle constriction (bronchospasm)
Airway inflammation
Increased mucus production
These cause airway narrowing, increased airway resistance, wheezing, and dyspnea.
Question 7: Iron Deficiency Anemia
Q: A patient presents with fatigue and pallor. Labs show microcytic, hypochromic anemia. What
is the underlying pathophysiology?
A: Iron deficiency impairs hemoglobin synthesis, leading to the production of smaller
(microcytic), pale (hypochromic) red blood cells. This reduces oxygen-carrying capacity,
causing tissue hypoxia, which manifests as fatigue, pallor, and tachycardia.
Question 8: Stroke (Ischemic)
Q: What is the pathophysiologic mechanism of ischemic stroke?
,A: Ischemic stroke occurs due to arterial occlusion (commonly from a thrombus or embolus),
leading to reduced cerebral blood flow. This causes neuronal ischemia, ATP depletion,
cytotoxic edema, and cell death in affected brain regions if not reversed quickly.
Question 9: Systemic Lupus Erythematosus (SLE)
Q: How does autoimmunity contribute to the multi-system effects of SLE?
A: In SLE, autoantibodies (e.g., ANA, anti-dsDNA) form immune complexes that deposit in
tissues like skin, kidneys, and joints. These complexes trigger complement activation, leading
to inflammation, vasculitis, and tissue damage, resulting in the multisystemic symptoms.
Question 10: Alzheimer’s Disease
Q: Describe the pathophysiological changes in the brain associated with Alzheimer’s disease.
A: Alzheimer’s involves:
Amyloid-beta plaque accumulation outside neurons
Neurofibrillary tangles (tau protein) inside neurons
These changes cause neuronal death, synaptic loss, and cortical atrophy, leading to
progressive memory loss, cognitive decline, and functional impairment.
Question 11: Sepsis and Septic Shock
Q: Describe the pathophysiology of septic shock.
A: Septic shock arises from an overwhelming infection that triggers a systemic inflammatory
response. Cytokine release leads to widespread vasodilation, increased capillary
permeability, and decreased systemic vascular resistance. This causes hypotension, tissue
hypoperfusion, and ultimately multiple organ dysfunction syndrome (MODS) if untreated.
Question 12: Hepatic Encephalopathy
Q: What causes hepatic encephalopathy in liver failure?
A: The failing liver cannot detoxify ammonia, a byproduct of protein metabolism. Ammonia
crosses the blood-brain barrier and alters neurotransmission, leading to cerebral edema, altered
mental status, asterixis, and potentially coma.
Question 13: Graves' Disease
, Q: What is the pathophysiology behind Graves' disease?
A: Graves' is an autoimmune hyperthyroidism. TSI antibodies (thyroid-stimulating
immunoglobulins) mimic TSH, stimulating the thyroid to overproduce T3 and T4. This leads to
increased metabolism, goiter, and symptoms like tachycardia, weight loss, and
exophthalmos.
Question 14: Multiple Sclerosis (MS)
Q: What is the pathophysiology of multiple sclerosis?
A: MS is an autoimmune disease where T cells attack myelin in the central nervous system,
causing demyelination, inflammation, and axonal damage. This disrupts nerve signal
conduction, resulting in motor, sensory, and cognitive impairments.
Question 15: Diabetic Ketoacidosis (DKA)
Q: Explain the key pathophysiological events in DKA.
A: In type 1 diabetes, lack of insulin prevents glucose uptake, leading to lipolysis and ketone
production for energy. Accumulation of ketones causes metabolic acidosis, dehydration,
electrolyte imbalances, and Kussmaul respirations.
Question 16: Chronic Kidney Disease (CKD)
Q: What are the systemic consequences of CKD?
A: CKD leads to:
Uremia (toxin buildup)
Anemia (↓ erythropoietin)
Hypertension (RAAS activation)
Osteodystrophy (↓ vitamin D activation and ↑ phosphate)
Metabolic acidosis
This contributes to multisystem dysfunction.
Question 17: Peptic Ulcer Disease
Q: How does H. pylori infection contribute to peptic ulcer formation?
